ValveXchange Wins The Third Annual Faegre Benson Venture Showcase Award Presented At BioWest 2007



ValveXchange (Aurora) won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 Conference & Expo. The announcement is made by Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards Luncheon at the Grand Hyatt Friday.

ValveXchange holds patented technology on a two-piece bioprosthetic tissue valve that resolves the compromises between conventional mechanical and tissue heart valves. The company's technology is easily adopted by surgeons with a clear regulatory path and a $1.2 billion market opportunity. ValveXchange has exclusively licensed its core technology, invented by founder Ivan Vesely, PhD, from The Cleveland Clinic Foundation. Thus far, the company has been financed by seed funding from the founder and three SBIR grants. That funding has allowed for prototypes developed with proof of concept, two-piece exchangeable tissue valve, functional and mechanical tests, in vitro testing of prototypes, validated performance and in vivo testing. Going forward, the company is initiating recruitment of Angel and Series A Financing of $2.5 million to bring it to the Clinical Trial stage. For more information, call Dr. Vesely, Founder and CSO, at 323-481-9643 or go to



ValveXchange Wins The Third Annual Faegre Benson Venture Showcase Award Presented At BioWest 2007